Latest filing published 26 Jan 2023 for Genscript Biotech Corporation.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pan Jiuan: trading record in brief
All filings by Pan Jiuan on record concern Genscript Biotech Corporation. We count 2 filings; the first trade dates from 1 September 2020 and the latest from 18 January 2023.
No open-market sale appears; the market trades are 2 purchases. The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2023: 1 purchase and no sales on the market.
Most recently, on 26 January 2023, the filings show an open-market purchase in Genscript Biotech Corporation. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Pan Jiuan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,929 sharesShareXHKGHKEX:DA20230126E00499Canonical exit: 18 Apr 2023 (T+90)
- 270,000 sharesShareXHKGHKEX:DA20200903E00407Canonical exit: 30 Nov 2020 (T+90)
2 of 2 declarations
